Pathogenesis and outcome of VA1 astrovirus infection in the human brain are defined by disruption of neural functions and imbalanced host immune responses.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
28
03
2023
accepted:
06
07
2023
medline:
21
8
2023
pubmed:
18
8
2023
entrez:
18
8
2023
Statut:
epublish
Résumé
Astroviruses (AstVs) can cause of severe infection of the central nervous system (CNS) in immunocompromised individuals. Here, we identified a human AstV of the VA1 genotype, HAstV-NIH, as the cause of fatal encephalitis in an immunocompromised adult. We investigated the cells targeted by AstV, neurophysiological changes, and host responses by analyzing gene expression, protein expression, and cellular morphology in brain tissue from three cases of AstV neurologic disease (AstV-ND). We demonstrate that neurons are the principal cells targeted by AstV in the brain and that the cerebellum and brainstem have the highest burden of infection. Detection of VA1 AstV in interconnected brain structures such as thalamus, deep cerebellar nuclei, Purkinje cells, and pontine nuclei indicates that AstV may spread between connected neurons transsynaptically. We found transcriptional dysregulation of neural functions and disruption of both excitatory and inhibitory synaptic innervation of infected neurons. Importantly, transcriptional dysregulation of neural functions occurred in fatal cases, but not in a patient that survived AstV-ND. We show that the innate, but not adaptive immune response was transcriptionally driving host defense in the brain of immunocompromised patients with AstV-ND. Both transcriptome and molecular pathology studies showed that most of the cellular changes were associated with CNS-intrinsic cells involved in phagocytosis and injury repair (microglia, perivascular/parenchymal border macrophages, and astrocytes), but not CNS-extrinsic cells (T and B cells), suggesting an imbalance of innate and adaptive immune responses to AstV infection in the brain as a result of the underlying immunodeficiencies. These results show that VA1 AstV infection of the brain in immunocompromised humans is associated with imbalanced host defense responses, disruption of neuronal somatodendritic compartments and synapses and increased phagocytic cellular activity. Improved understanding of the response to viral infections of the human CNS may provide clues for how to manipulate these processes to improve outcomes.
Identifiants
pubmed: 37595007
doi: 10.1371/journal.ppat.1011544
pii: PPATHOGENS-D-23-00552
pmc: PMC10438012
doi:
Types de publication
Journal Article
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1011544Informations de copyright
Copyright: This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS Negl Trop Dis. 2016 Sep 12;10(9):e0004980
pubmed: 27617450
Acta Vet Scand. 2019 Jun 24;61(1):31
pubmed: 31234899
Annu Rev Virol. 2017 Sep 29;4(1):327-348
pubmed: 28715976
Brief Bioinform. 2019 Jul 19;20(4):1160-1166
pubmed: 28968734
Emerg Infect Dis. 2010 Jun;16(6):918-25
pubmed: 20507741
Nat Rev Microbiol. 2010 Sep;8(9):645-55
pubmed: 20706281
Viruses. 2020 Dec 30;13(1):
pubmed: 33396858
Nature. 2016 Jun 22;534(7608):538-43
pubmed: 27337340
J Gen Virol. 2009 Dec;90(Pt 12):2965-2972
pubmed: 19692544
Viruses. 2017 Jan 18;9(1):
pubmed: 28106800
Clin Infect Dis. 2015 Mar 15;60(6):881-8
pubmed: 25572899
Pediatr Blood Cancer. 2021 Dec;68(12):e29286
pubmed: 34411414
J Pediatric Infect Dis Soc. 2022 Sep 29;11(9):408-412
pubmed: 35849135
Pathog Immun. 2016 May;1(1):12-40
pubmed: 27294212
Mol Brain. 2017 Aug 29;10(1):40
pubmed: 28851400
JAMA Neurol. 2015 Feb;72(2):143-4
pubmed: 25485794
Neuron. 2019 Sep 4;103(5):771-783
pubmed: 31487528
N Engl J Med. 2019 Jun 13;380(24):2327-2340
pubmed: 31189036
Front Immunol. 2019 Mar 26;10:586
pubmed: 30984175
Nucleic Acids Res. 2019 Jul 2;47(W1):W191-W198
pubmed: 31066453
J Clin Microbiol. 2010 Dec;48(12):4392-6
pubmed: 20926705
J Neuroimmunol. 2004 Dec;157(1-2):163-75
pubmed: 15579294
Nat Rev Neurosci. 2011 Jun;12(6):345-57
pubmed: 21587289
Transbound Emerg Dis. 2017 Jun;64(3):677-682
pubmed: 28224712
Clin Infect Dis. 2021 Oct 20;73(8):1404-1411
pubmed: 34050746
J Clin Virol. 2016 May;78:66-70
pubmed: 26991054
Ann Neurol. 1992 Sep;32(3):321-9
pubmed: 1416802
Emerg Infect Dis. 2013;19(9):1385-92
pubmed: 23965613
Immunity. 2017 Jun 20;46(6):891-909
pubmed: 28636958
PLoS One. 2011;6(11):e27483
pubmed: 22096580
Trans R Soc Trop Med Hyg. 2009 Feb;103(2):109-21
pubmed: 18799177
J Clin Microbiol. 2014 Sep;52(9):3318-24
pubmed: 24989603
Syst Biol. 2012 May;61(3):539-42
pubmed: 22357727
Mol Biol Evol. 2001 May;18(5):691-9
pubmed: 11319253
J Neurovirol. 2007 Apr;13(2):107-17
pubmed: 17505979
Neuron. 2014 Jan 22;81(2):229-48
pubmed: 24462092
Handb Clin Neurol. 2014;123:225-47
pubmed: 25015488
Nat Rev Immunol. 2003 Jun;3(6):493-502
pubmed: 12776209
Curr Opin Infect Dis. 2021 Dec 1;34(6):627-634
pubmed: 34751182
Nat Protoc. 2019 Mar;14(3):703-721
pubmed: 30804569
Mol Biol Evol. 2015 Jan;32(1):268-74
pubmed: 25371430
Curr Neurol Neurosci Rep. 2021 May 26;21(7):37
pubmed: 34037866
Mol Biol Evol. 2018 Feb 1;35(2):518-522
pubmed: 29077904
PLoS One. 2011;6(10):e24371
pubmed: 21991302
J Med Case Rep. 2019 Nov 23;13(1):341
pubmed: 31757225
Transpl Infect Dis. 2016 Dec;18(6):960-964
pubmed: 27632248
Cell Host Microbe. 2013 Apr 17;13(4):379-93
pubmed: 23601101
Brain Pathol. 1999 Apr;9(2):209-17
pubmed: 10219738
Annu Rev Immunol. 2019 Apr 26;37:73-95
pubmed: 31026414
Elife. 2021 Feb 18;10:
pubmed: 33599611
Emerg Infect Dis. 2016 May;22(5):846-53
pubmed: 27088842
Viruses. 2017 Feb 18;9(2):
pubmed: 28218712
J Pediatric Infect Dis Soc. 2015 Sep;4(3):e53-7
pubmed: 26407445
World Allergy Organ J. 2019 Mar 22;12(3):100018
pubmed: 30937141
Nat Methods. 2017 Jun;14(6):587-589
pubmed: 28481363
Emerg Infect Dis. 2017 Dec;23(12):1982-1993
pubmed: 29148391
J Neuropathol Exp Neurol. 2009 Oct;68(10):1061-72
pubmed: 19918118
Clin Infect Dis. 2015 Mar 15;60(6):919-23
pubmed: 25572898
PLoS Pathog. 2011 Sep;7(9):e1002213
pubmed: 21909266
Trends Microbiol. 2015 May;23(5):283-8
pubmed: 25639651
Annu Rev Virol. 2018 Sep 29;5(1):255-272
pubmed: 30265628
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Clin Microbiol Rev. 2018 Aug 29;31(4):
pubmed: 30158300
Curr HIV/AIDS Rep. 2022 Dec;19(6):580-591
pubmed: 36181625
Front Vet Sci. 2016 Oct 11;3:91
pubmed: 27781208